Patient Guide to Osteoporosis in Men

摘要

Testosterone therapy appears to increase BMD in men with low levels of this male hormone (below 200 nanograms per deciliter, or ng/dL), but its effect on fractures has not been studied. So, unless men have a clear need for testosterone therapy other than for bone health, an FDA-approved osteoporosis medicine is usually the first choice for these men. This is especially true if they have a high fracture risk.